Listen to the presentation of Dr. Nicole Faust on:
“Revolutionizing AAV Vector Production”
Session description: Upscaling GMP production of viral vectors is currently one of the big technical challenges in gene therapies. CEVEC has developed the fully scalable CAP-GT platform, based on serum-free suspension cells which can efficiently produce lentivirus (LV), adenovirus (AV) and adeno-associated virus (AAV) vectors at industrial scale. The session will focus on the newly developed AAV packaging system, allowing the helper virus-free stable production of AAV vectors without the need of a transient transfection step.
Live Session Time: Tuesday, April 10, 4-5pm CEST / 3-4pm BST / 10-11am EST